Studies and Patents
A Commitment to ExcellenceClick to view PDF
Scientists around the world have conducted numerous studies to research the effectiveness of transfer factor molecules. 4Life scientists have continued this legacy by commissioning third-party studies and in-house scientific tests to understand just how well 4Life Transfer Factor® products interact with specific immune cells.
One test shows that 4Life Transfer Factor products can increase the immune system effectiveness of Natural Killer cells (important first responders) by up to 437%.
Click to view animation
Another preliminary scientific test suggests that 4Life Transfer Factor® Tri-Factor® Formula strengthens your immune system guard by increasing the number of protective salivary IgA antibodies by up to 73%. And, everyone tested experienced an increase!
4Life's progressive science and pursuit of patent protection strengthen the 4Life business opportunity. Patents reinforce 4Life’s credibility in the wellness industry and demonstrate the company’s long-term commitment to exclusivity and stability.
4Life holds four U.S. patents and 30 international patents.
The current U.S. patents include:
• U.S. Patent #6,468,534: A technique patent for the extraction process of transfer factors from chicken egg yolk.
• U.S. Patent #6,866,868: A method patent for the exclusive combination of transfer factors from chicken egg yolk and cow colostrum.
• U.S. Patent #7,815,943: A composition patent that protects the 4Life Transfer Factor® Cardio formula and ensures long-term exclusivity through 2025.
• U.S. Patent #9,028,882: A composition patent that protects the unique formulation of 4Life Transfer Factor® RioVida Burst® Tri-Factor® Formula through 2026.